Difference between revisions of "Matsuyama S, et al, J Virol (2010), cited as Ref 11 in DOI: 10.1007/s11886-020-01293-2 (Q11005)"
Jump to navigation
Jump to search
(Created claim: Fourth Author string (P152): Kawase M, #quickstatements; #temporary_batch_1592835703983) |
(Created claim: Fifth Author string (P153): Takeda M, #quickstatements; #temporary_batch_1592835784350) |
||
| Property / Fifth Author string | |||
| + | Takeda M | ||
| Property / Fifth Author string: Takeda M / rank | |||
| + | Normal rank | ||
Revision as of 14:23, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Matsuyama S, et al, J Virol (2010), cited as Ref 11 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2 (English)
0 references
2010
0 references
Matsuyama S
0 references
Nagata N
0 references
Shirato K
0 references
Kawase M
0 references
Takeda M
0 references
